Abigail Johnson — Form 4 insider transactions
Fidelity Management & Research (FMR) — Full 13F portfolio →
Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.
| Transaction date | Activity | Security | Shares | Price | Total | Filing |
|---|---|---|---|---|---|---|
| 2026-11-10 | Sell | Avalyn Pharma Inc. | 47,889 | $30.28 | $1,450,079 | SEC filing |
| 2026-11-10 | Sell | Avalyn Pharma Inc. | 5,565 | $29.56 | $164,501 | SEC filing |
| 2026-11-09 | Sell | Avalyn Pharma Inc. | 1,339 | $29.75 | $39,835 | SEC filing |
| 2026-11-09 | Sell | Avalyn Pharma Inc. | 173,661 | $29.06 | $5,046,589 | SEC filing |
| 2026-06-26 | Sell | Beam Therapeutics Inc. | 251,488 | $35.26 | $8,867,467 | SEC filing |
| 2026-06-25 | Sell | Beam Therapeutics Inc. | 33,372 | $35.12 | $1,172,025 | SEC filing |
| 2026-05-01 | Conversion | Avalyn Pharma Inc. | 377,948 | — | — | SEC filing |
| 2026-05-01 | Conversion | Avalyn Pharma Inc. | 225,843 | — | — | SEC filing |
| 2026-05-01 | Conversion | Avalyn Pharma Inc. | 872,868 | — | — | SEC filing |
| 2026-05-01 | Conversion | Avalyn Pharma Inc. | 80,291 | — | — | SEC filing |
| 2026-05-01 | Conversion | Avalyn Pharma Inc. | 727,585 | — | — | SEC filing |
How Form 4 differs from 13F
13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.